InvestorsHub Logo
Followers 69
Posts 7614
Boards Moderated 0
Alias Born 01/10/2014

Re: Investor2014 post# 410360

Monday, 04/10/2023 9:05:19 AM

Monday, April 10, 2023 9:05:19 AM

Post# of 463460
My guess is many companies will be pitching hard at this "dog and pony show" as capital funding for the sector has dried up. Thankfully Anavex has cash in the bank and a frugal CEO. Unfortunate for other baby biotechs, well... some are in trouble.

The simply horrible reception $ANVS received on it's recent stock offering could be the death knell for all low cash on hand biotechs.

This will be particularly true if equity as an asset class remains out of favor versus fixed income.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News